merck glp 1 drug Medicare will negotiate Novo's GLP-1 price. Here's what that means for Ozempic, Wegovy GLP-1 | Summary

As states cut Medicaid coverage for GLP-1 drugs, access to obesity treatment is increasingly tied to incomeraising questions for both Medicaid and Medicare.

IntroductionGlucagon-like peptide-1 receptor agonists (GLP-1 RA) are novel agents with proven cardiovascular (CV) benefits

Commonly prescribed GLP-1RAs: Exenatide (Byetta, Bydureon) Liraglutide (Victoza, Saxenda) Dulaglutide (Trulicity) Semaglutide (Ozempic, Wegovy, Rybelsus) Tirzepatide (Mounjaro) Study overview: What was investigated

The tennis legend says she needed extra medical support after giving birth to her second daughter.

Originally developed to treat type 2 diabetes (T2D), these drugs have since delivered major advances in managing obesity and cardiovascular risk reduction